Herantis Pharma Oyj Stock Earnings Per Share
| HRTIS Stock | EUR 1.49 0.07 4.49% |
Herantis Pharma Oyj fundamentals help investors to digest information that contributes to Herantis Pharma's financial success or failures. It also enables traders to predict the movement of Herantis Stock. The fundamental analysis module provides a way to measure Herantis Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Herantis Pharma stock.
Herantis |
Herantis Pharma Oyj Company Earnings Per Share Analysis
Herantis Pharma's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Herantis Pharma Earnings Per Share | (1.25) X |
Most of Herantis Pharma's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Herantis Pharma Oyj is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, Herantis Pharma Oyj has an Earnings Per Share of -1.251 times. This is 114.95% lower than that of the Pharmaceuticals sector and 73.88% lower than that of the Health Care industry. The earnings per share for all Finland stocks is 140.1% higher than that of the company.
Herantis Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Herantis Pharma's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Herantis Pharma could also be used in its relative valuation, which is a method of valuing Herantis Pharma by comparing valuation metrics of similar companies.Herantis Pharma is currently under evaluation in earnings per share category among its peers.
Herantis Fundamentals
| Return On Equity | -13.37 | |||
| Return On Asset | -0.6 | |||
| Current Valuation | 25.86 M | |||
| Shares Outstanding | 16.91 M | |||
| Shares Owned By Insiders | 31.52 % | |||
| Shares Owned By Institutions | 32.60 % | |||
| Price To Earning | (7.20) X | |||
| Price To Book | 15.17 X | |||
| Gross Profit | 90 K | |||
| EBITDA | (9.74 M) | |||
| Net Income | (12.77 M) | |||
| Cash And Equivalents | 7.86 M | |||
| Cash Per Share | 0.81 X | |||
| Total Debt | 6.29 M | |||
| Debt To Equity | 0.95 % | |||
| Current Ratio | 1.54 X | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | (9.93 M) | |||
| Earnings Per Share | (1.25) X | |||
| Target Price | 2.1 | |||
| Number Of Employees | 13 | |||
| Beta | 0.51 | |||
| Market Capitalization | 39.58 M | |||
| Total Asset | 7.76 M | |||
| Retained Earnings | (27 M) | |||
| Working Capital | 5 M | |||
| Current Asset | 6 M | |||
| Current Liabilities | 1000 K | |||
| Z Score | -3.9 | |||
| Net Asset | 7.76 M |
About Herantis Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Herantis Pharma Oyj's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Herantis Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Herantis Pharma Oyj based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Herantis Stock
Herantis Pharma financial ratios help investors to determine whether Herantis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Herantis with respect to the benefits of owning Herantis Pharma security.